Research programme: monocarboxylic acid transporter inhibitors - AstraZeneca
Alternative Names: AR-C117977Latest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator AstraZeneca
- Class Heterocyclic compounds; Small molecules
- Mechanism of Action Monocarboxylic acid transporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Transplant rejection
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Transplant-rejection(Prevention) in United Kingdom